Adoptive Immunotherapy of Established Pulmonary Metastases with LAK Cells and Recombinant Interleukin-2

James J. Mulé, Suyu Shu, Susan Schwarz, +1

Science

Lak CellsImmunologyImmunologic MechanismImmunotherapyAdoptive Immunotherapy +15

Depletion of CD4+CD25+ Regulatory Cells Augments the Generation of Specific Immune T Cells in Tumor-Draining Lymph Nodes

Hiroshi Tanaka, Junta Tanaka, Jørgen Kjaergäard, +1

Journal of Immunotherapy

T-regulatory CellImmunologyImmune RegulationRegulatory T CellsCd4 T Cell Responses +16

Therapeutic efficacy of OX-40 receptor antibody depends on tumor immunogenicity and anatomic site of tumor growth.

Jørgen Kjaergäard, Junta Tanaka, Julian A. Kim, +3

PubMed

ImmunologyImmunoeditingPathologyMca 205Immunotherapy +16

Adoptive immunotherapy of newly induced murine sarcomas.

Suyu Shu, Steven A. Rosenberg

PubMed

Mca 106ImmunologyPathologyImmune Cell TherapyImmunotherapy +14

Tumor-Induced CD11b+Gr-1+ Myeloid Cells Suppress T Cell Sensitization in Tumor-Draining Lymph Nodes

Satoshi Watanabe, Katsuya Deguchi, Rongxiu Zheng, +4

The Journal of Immunology

CXC Chemokine Ligand 9/Monokine Induced by IFN-γ Production by Tumor Cells Is Critical for T Cell-Mediated Suppression of Cutaneous Tumors

Anton V. Gorbachev, Hirohito Kobayashi, Daisuke Kudo, +5

The Journal of Immunology

Immunotherapy of Malignancy by <i>In Vivo</i> Gene Transfer into Tumors

Gary J. Nabel, Alfred E. Chang, Elizabeth G. Nabel, +4

Human Gene Therapy

CD4+ T Cells in Adoptive Immunotherapy and the Indirect Mechanism of Tumor Rejection

Peter A. Cohen, Liaomin Peng, Gregory E. Plautz, +3

Critical Reviews in Immunology

T-regulatory CellImmunologyAntigen ProcessingImmune Cell TherapyIndirect Mechanism +16

Infiltration of tumors by systemically transferred tumor-reactive T lymphocytes is required for antitumor efficacy.

Shigehiko Mukai, Jørgen Kjaergäard, Suyu Shu, +1

PubMed

ImmunologyAntitumor EfficacyImmunologic MechanismMetronomic ChemotherapyImmune Cell Therapy +18

Purification of L-Selectinlow Cells Promotes the Generation of Highly Potent CD4 Antitumor Effector T Lymphocytes

Hiroshi Kagamu, Suyu Shu

The Journal of Immunology